Download This Bill in Microsoft Word format
H. 4382
STATUS INFORMATION
General Bill
Sponsors: Rep. Sessions
Document Path: LC-0238VR25.docx
Introduced in the House on April 23, 2025
Introduced in the Senate on April 30, 2026
Last Amended on May 12, 2026
Currently residing in the House
Summary: Nonprescription Ephedrine Products
HISTORY OF LEGISLATIVE ACTIONS
| Date | Body | Action Description with journal page number |
|---|---|---|
| 4/23/2025 | House | Introduced and read first time (House Journal-page 49) |
| 4/23/2025 | House | Referred to Committee on Labor, Commerce and Industry (House Journal-page 49) |
| 4/2/2026 | House | Committee report: Favorable with amendment Labor, Commerce and Industry (House Journal-page 17) |
| 4/15/2026 | House | Requests for debate-Rep(s). Frank, Edgerton, Pace, Beach, Harris, Gilreath, Cromer, Terribile (House Journal-page 34) |
| 4/23/2026 | House | Debate adjourned (House Journal-page 170) |
| 4/29/2026 | House | Amended (House Journal-page 148) |
| 4/29/2026 | House | Read second time (House Journal-page 148) |
| 4/29/2026 | House | Roll call Yeas-112 Nays-0 (House Journal-page 152) |
| 4/30/2026 | House | Read third time and sent to Senate (House Journal-page 125) |
| 4/30/2026 | Senate | Introduced and read first time (Senate Journal-page 7) |
| 4/30/2026 | Senate | Referred to Committee on Medical Affairs (Senate Journal-page 7) |
| 5/7/2026 | Senate | Committee report: Favorable Medical Affairs (Senate Journal-page 6) |
| 5/12/2026 | Senate | Amended (Senate Journal-page 54) |
| 5/12/2026 | Senate | Read second time (Senate Journal-page 54) |
| 5/12/2026 | Senate | Roll call Ayes-46 Nays-0 (Senate Journal-page 54) |
| 5/13/2026 | Scrivener's error corrected | |
| 5/13/2026 | Senate | Read third time and returned to House with amendments (Senate Journal-page 60) |
| 5/14/2026 | Scrivener's error corrected | |
| 5/14/2026 | House | Concurred in Senate amendment and enrolled (House Journal-page 36) |
| 5/14/2026 | House | Roll call Yeas-111 Nays-0 (House Journal-page 37) |
| 5/15/2026 | Ratified R 248 | |
| 5/19/2026 | Signed By Governor |
View the latest legislative information at the website
VERSIONS OF THIS BILL
4/23/2025
4/2/2026
4/29/2026
5/7/2026
5/12/2026
5/13/2026
5/14/2026
(R248, H4382)
AN ACT TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 44-53-398, RELATING TO THE SALE OF PRODUCTS CONTAINING EPHEDRINE, PSEUDOEPHEDRINE, OR PHENYLPROPANOLAMINE, SO AS TO REQUIRE THAT MANUFACTURERS OF THESE PRODUCTS PAY MONTHLY FEES ASSOCIATED WITH DATA COLLECTION, TO ESTABLISH A PENALTY FOR MANUFACTURERS THAT FAIL TO COMPLY, AND FOR OTHER PURPOSES.
Be it enacted by the General Assembly of the State of South Carolina:
Nonprescription ephedrine, pseudoephedrine, and phenylpropanolamine products
SECTION 1. Section 44-53-398(D) of the S.C. Code is amended to read:
(D)(1) A retailer selling nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine shall require the purchaser to produce a government issued photo identification showing the date of birth of the person and require the purchaser to sign an electronic log showing the date and time of the transaction, the person's name and address, the type, issuing governmental entity, identification number, and the amount of the compound, mixture, or preparation. The retailer shall determine that the name entered in the log corresponds to the name on the identification and that the date and time entered are correct and shall enter in the log the name of the product and the quantity sold. The retailer shall ensure that the product is delivered directly into the custody of that purchaser. The log must include a notice to purchasers that entering false statements or misrepresentations in the log may subject the purchaser to criminal penalties.
(2) Before completing a sale of a product regulated by this section, the retailer electronically shall transmit the information entered in the log to a data collection system provided by the administrator of the data collection system. The system must collect this data in real time and generate a stop sale alert if the sale would result in a violation of subsection (B) or a federal quantity restriction, which must be assessed on the basis of sales or purchases made in any state to the extent that information is available in the data collection system. If the retailer receives a stop sale alert, the retailer must not complete the sale unless the retailer, upon notifying the purchaser the sale cannot be completed, reasonably fears bodily harm if he denies the sale due to the stop sale alert. A product regulated by this section may not be sold without being reported to the data collection system unless the system is experiencing temporary technical difficulties that prevent a retailer from reporting the information to the system, and in that case, the retailer shall enter the necessary information in a written log, which must subsequently be entered into the electronic log within three business days of each business day that the electronic log was not operational. A retailer using a written log under these circumstances is immune from liability during the time the system is temporarily disabled.
(3) Any information entered in the electronic log that is retained by a retailer, or information maintained by a retailer pursuant to subsection (J)(2), is confidential and not a public record as defined in Section 30-4-20(C) of the Freedom of Information Act. A retailer or an employee or agent of a retailer who in good faith releases information in a log to federal, state, or local law enforcement authorities is immune from civil liability for the release unless the release constitutes gross negligence or intentional, wanton, or wilful misrepresentation.
(4)(a) Beginning October 1, 2026, any manufacturer of nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine sold in or into the State must, on a monthly basis, pay fees to the administrator of the data collection system described in item (2).
(b) The administrator of the data collection system and all manufacturers of nonprescription products containing ephedrine, pseudoephedrine, or phenylpropanolamine sold in or into the State shall, on an annual basis, negotiate and establish the monthly fee required pursuant to subitem (a) on a per-product, per-transaction, year-over-year basis by an amount equal to or less than the amount of the monthly fee paid by manufacturers in the previous year, or an increased amount of less than ten percent of the monthly fee paid by manufacturers in the previous year. The amount of the negotiated monthly fee may only be established at an amount equal to or more than ten percent of the monthly fee paid by manufacturers in the previous year if the administrator of the data collection system can show that the increase is directly attributable to costs to administer the data collection system.
(c) At the request of the State Law Enforcement Division, manufacturers required to pay fees pursuant to subitem (a) must provide written documentation demonstrating that they have paid such fees.
(d) For purposes of this item, "administrator of the data collection system" means the entity responsible for developing, implementing, and maintaining the data collection system described in item (2).
Penalties
SECTION 2. Section 44-53-398(H)(1) and (4) of the S.C. Code is amended to read:
(1) Except as otherwise provided in this section, it is unlawful for a retailer knowingly to violate subsection (A), (B)(1), (C), (D)(1), (D)(2), or (D)(4), and it is unlawful for a person knowingly to violate subsection (B)(2), (E), or (F).
(4)(a) A retailer convicted of a violation of subsection (D)(1), (D)(2), or (J)(2) is guilty of a misdemeanor and, upon conviction, for a first offense, must be fined not more than one thousand dollars and not less than five hundred dollars. Upon conviction for a second offense, a retailer must be fined not more than five thousand dollars and not less than one thousand dollars. Upon conviction for a third or subsequent offense, a person must be fined not more than ten thousand dollars and not less than five thousand dollars.
(b) A manufacturer that violates subsection (D)(4) must be fined:
(i) for a first offense, not more than one thousand dollars and not less than five hundred dollars;
(ii) for a second offense, not more than five thousand dollars and not less than one thousand dollars; and
(iii) for a third or subsequent offense, not more than ten thousand dollars and not less than five thousand dollars.
Time effective
SECTION 3. This act takes effect upon approval by the Governor.
Ratified the 15th day of May, 2026.
Approved the _____________ day of _________________________________________2026.
This web page was last updated on May 15, 2026 at 5:13 PM